The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study

@article{Siskind2019TheIO,
  title={The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study},
  author={Dan J. Siskind and Tim Reddel and James Hunter MacCabe and Stephen R Kisely},
  journal={Psychopharmacology},
  year={2019},
  volume={236},
  pages={1931-1935}
}
BackgroundClozapine is the most effective medication for the positive symptoms of treatment-refractory schizophrenia. Although clozapine use is associated with fewer admissions, less is known about the impact of clozapine cessation on hospitalisation.AimsThe aims of this study were to investigate whether clozapine-reduced psychiatric inpatient admissions and bed days, and investigate patient factors associated with these changes from a sample of 1906 people commenced on clozapine.MethodsAll… 

References

SHOWING 1-10 OF 19 REFERENCES

41.3 COULD CLOZAPINE REDUCE VIOLENT OFFENDING?

In patients with psychotic disorders, clozapine treatment is associated with a lower rate of violent offending compared to olanzapine, and this effect might reduce offending through a direct effect on psychotic symptoms, or indirectly through changes in lifestyle, including use of alcohol.

The impact of clozapine on hospital use: a systematic review and meta‐analysis

A systematic review and meta‐analysis of studies reporting the impact of clozapine on hospital use in people with a psychotic illness and its role in clinical practice is performed.

International trends in clozapine use: a study in 17 countries

This study aimed to assess clozapine use trends on an international scale, using standardised criteria for data analysis.

Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital

Rates of clozapine and high-dose antipsychotic prescribing were higher than in other psychiatric settings, while polypharmacy prescribing rates were lower, suggesting a treatment-resistant and aggressive population.

Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

An international group of methodologists, researchers, and journal editors sets out guidelines to improve reports of observational studies.

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

The authors present consensus guidelines that operationalize criteria for determining and reporting treatment resistance, adequate treatment, and treatment response, providing a benchmark for research and clinical translation in schizophrenia.

One year outcome in first episode schizophrenia. Predictors of relapse.

It is suggested that treatment compliance and early premorbid adjustment level seem to be important predictors of relapse rate in first episode schizophrenia.

Factors associated with changes in hospitalisation in patients prescribed clozapine

Clozapine reduces the number of inpatient days, regardless of the chronicity of the illness at the time clozapines was started, and reduction in bed days is greater in younger patients, suggesting early initiation of clozAPine may be beneficial.

The global costs of schizophrenia.

All cost-of-illness estimates highlight the heavy societal burden of schizophrenia, and to better interpret and explain the large within- and across-country differences that exist are highlighted.